H. RALPH SNODGRASS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for H. RALPH SNODGRASS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of H. RALPH SNODGRASS. H. RALPH SNODGRASS is PRES./CHIEF SCIENTIFIC OFFICER in VistaGen Therapeutics, Inc. ($NA).
Latest Insider Trading Transactions of H. RALPH SNODGRASS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.77 | 150,000 | 265,500 | 150,000 | |
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Grant | A | 0.45 | 5,000 | 2,261 | 87,724 | 82.7 K to 87.7 K (+6.04 %) |
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.77 | 150,000 | 265,500 | 150,000 | |
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Grant | A | 0.45 | 5,000 | 2,261 | 87,724 | 82.7 K to 87.7 K (+6.04 %) |
| Jul 01 2020 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Grant | A | 0.45 | 5,000 | 2,240 | 67,724 | 62.7 K to 67.7 K (+7.97 %) |
| Apr 27 2020 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 0.40 | 150,000 | 59,700 | 150,000 | |
| Nov 21 2019 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Buy | P | 0.34 | 15,000 | 5,100 | 15,000 | 0 to 15 K |
| Oct 22 2019 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.41 | 175,000 | 246,750 | 175,000 | |
| May 28 2019 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.00 | 150,000 | 150,000 | 150,000 | |
| Mar 14 2019 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | M | 1.50 | 2,500 | 3,750 | 0 | |
| Mar 14 2019 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Buy | M | 1.50 | 2,500 | 3,750 | 62,724 | 60.2 K to 62.7 K (+4.15 %) |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.50 | 125,000 | 187,500 | 125,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 1.96 | 125,000 | 245,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.50 | 80,000 | 120,000 | 80,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 3.80 | 80,000 | 304,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.50 | 125,000 | 187,500 | 125,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 3.49 | 125,000 | 436,250 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.50 | 12,500 | 18,750 | 12,500 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 10.00 | 12,500 | 125,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.50 | 1,250 | 1,875 | 1,250 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 10.00 | 1,250 | 12,500 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.50 | 2,500 | 3,750 | 2,500 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 10.00 | 2,500 | 25,000 | 0 | |
| Aug 06 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.27 | 125,000 | 158,750 | 125,000 | |
| Feb 05 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.16 | 175,000 | 203,000 | 175,000 | |
| Sep 20 2017 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.56 | 100,000 | 156,000 | 100,000 | |
| Apr 28 2017 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.96 | 125,000 | 245,000 | 125,000 | |
| Nov 10 2016 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 3.80 | 80,000 | 304,000 | 80,000 | |
| Jun 21 2016 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 3.49 | 125,000 | 436,250 | 125,000 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 7.00 | 150,000 | 1,050,000 | 150,000 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 9.25 | 150,000 | 1,387,500 | 0 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 7.00 | 100,000 | 700,000 | 100,000 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 10.00 | 100,000 | 1,000,000 | 0 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 7.00 | 7,500 | 52,500 | 7,500 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 10.00 | 7,500 | 75,000 | 0 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 7.00 | 2,500 | 17,500 | 2,500 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 10.00 | 2,500 | 25,000 | 0 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 7.00 | 50,000 | 350,000 | 50,000 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 12.80 | 50,000 | 640,000 | 0 | |
| Sep 03 2015 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 9.25 | 150,000 | 1,387,500 | 150,000 | |
| Mar 05 2013 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | J | 0.64 | 1,000,000 | 640,000 | 1,000,000 | |
| Dec 22 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | M | 0.88 | 113,636 | 100,000 | 0 | |
| Dec 22 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Buy | M | 0.88 | 113,636 | 100,000 | 1,204,468 | 1.1 M to 1.2 M (+10.42 %) |
| May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 3.85 | 50,000 | 192,500 | 50,000 | |
| May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 3.00 | 125,000 | 375,000 | 125,000 | |
| May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 3.00 | 75,000 | 225,000 | 75,000 | |
| May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 2.26 | 12,500 | 28,250 | 12,500 | |
| May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 2.26 | 25,000 | 56,500 | 25,000 | |
| May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 4.62 | 12,500 | 57,750 | 12,500 | |
| May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.58 | 20,000 | 31,600 | 20,000 | |
| May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.76 | 3,181 | 5,599 | 3,181 | |
| May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.76 | 56,818 | 100,000 | 56,818 | |
| May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Grant | A | 3.50 | 545,416 | 1,908,956 | 545,416 | 0 to 545.4 K |
Page: 1